Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10685)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chmielewska-Wilkoń D, Reggiardo G, Egan CG. Otilonium bromide in irritable bowel syndrome: A dose-ranging randomized double-blind placebo-controlled trial. World J Gastroenterol 2014; 20(34): 12283-12291 [PMID: 25232263 DOI: 10.3748/wjg.v20.i34.12283] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12283.htm |
| Number | Citing Articles |
| 1 |
Karin Sandoval, Ken Witt. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2015; 37: 433 doi: 10.1016/bs.seda.2015.05.008
|
| 2 |
Jin-Hyun Lee, Joong Il Kim, Myong Ki Baeg, Yun-Young Sunwoo, Kwangsun Do, Jung-Han Lee, Hye-Jung Kim, Ja Sung Choi, Jayoung Kim, Chang-Seob Seo, Hyeun-Kyoo Shin, Hyekyung Ha, Tae-Yong Park. Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial. Journal of Clinical Medicine 2019; 8(10): 1558 doi: 10.3390/jcm8101558
|
| 3 |
P. Layer, V. Andresen, H. Allescher, S. C. Bischoff, M. Claßen, S. Elsenbruch, M. Freitag, T. Frieling, M. Gebhard, M. Goebel-Stengel, W. Häuser, G. Holtmann, J. Keller, M. E. Kreis, W. Kruis, J. Langhorst, P. Lynen Jansen, A. Madisch, H. Mönnikes, S. Müller-Lissner, B. Niesler, C. Pehl, D. Pohl, M. Raithel, G. Röhrig-Herzog, M. Schemann, S. Schmiedel, J. Schwille-Kiuntke, M. Storr, J. C. Preiß, T. Andus, S. Buderus, U. Ehlert, M. Engel, A. Enninger, W. Fischbach, A. Gillessen, J. Gschossmann, F. Gundling, S. Haag, U. Helwig, S. Hollerbach, M. Karaus, M. Katschinski, H. Krammer, R. Kuhlbusch-Zicklam, H. Matthes, D. Menge, S. Miehlke, M. C. Posovszky, R. Schaefert, A. Schmidt-Choudhury, O. Schwandner, A. Schweinlin, H. Seidl, A. Stengel, J. Tesarz, I. van der Voort, W. Voderholzer, G. von Boyen, J. von Schönfeld, T. Wedel. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Zeitschrift für Gastroenterologie 2021; 59(12): 1323 doi: 10.1055/a-1591-4794
|
| 4 |
Akhilesh Wadhwa, Michael Camilleri, Madhusudan Grover. New and Investigational Agents for Irritable Bowel Syndrome. Current Gastroenterology Reports 2015; 17(12) doi: 10.1007/s11894-015-0473-x
|
| 5 |
Kwang Jae Lee. Pharmacologic Agents for Chronic Diarrhea. Intestinal Research 2015; 13(4): 306 doi: 10.5217/ir.2015.13.4.306
|
| 6 |
Pere Clavé, Jan Tack. Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis. Therapeutic Advances in Gastroenterology 2017; 10(3): 311 doi: 10.1177/1756283X16681708
|
| 7 |
Jun Zhao, Hui Zheng, Xin Wang, Xuefei Wang, Yunzhou Shi, Chaorong Xie, Qingfeng Tao, Da Li, Jingwen Sun, Junjian Tian, Junxia Gao, Huimin Liu, Suhua Shi, Jinxia Ni, Rongdan Xue, Hui Hu, Min Chen, Shuguang Yu, Zhigang Li. Efficacy of acupuncture in refractory irritable bowel syndrome patients: a randomized controlled trial. Frontiers of Medicine 2024; 18(4): 678 doi: 10.1007/s11684-024-1073-7
|
| 8 |
Joong Il Kim, Pumsoo Kim, Jin-Hyun Lee, Yoo-Jin Kim, Na-rae Yang, Myong Ki Baeg, Ja Sung Choi, Hye-Jung Kim, Jayoung Kim, Yun-Young Sunwoo, Jung-Han Lee, Hyekyung Ha, Tae-Yong Park. Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial. BMJ Open 2017; 7(11): e018362 doi: 10.1136/bmjopen-2017-018362
|
| 9 |
Ruijie Li, Fuping Chen, Xuanxuan He, Yuqing Feng, Qiaoqiao Pei, Dongke Wang, Xinghuang Liu, Jinsong Liu, Xiaohua Hou, Tao Bai. Nocebo response intensity and influencing factors in the randomized clinical trials of irritable bowel syndrome: A systematic review and meta-analysis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1018713
|
| 10 |
Darren M. Brenner, Brian E. Lacy. Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options. American Journal of Gastroenterology 2021; 116(8): 1587 doi: 10.14309/ajg.0000000000001266
|
| 11 |
Kai-Yue Huang, Feng-Yun Wang, Mi Lv, Xiang-Xue Ma, Xu-Dong Tang, Lin Lv. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World Journal of Gastroenterology 2023; 29(26): 4120-4135 doi: 10.3748/wjg.v29.i26.4120
Abstract(682) |
Core Tip(579) |
Full Article(HTML)(10722)
|
Full Article with Cover (PDF)-5521K(146)
|
Full Article (Word)-2306K(31)
|
Audio-356K(23)
|
Peer-Review Report-248K(62)
|
Answering Reviewers-199K(69)
|
Full Article (PDF)-5256K(781)
|
Full Article (XML)-263K(60)
|
Times Cited (22)
|
Total Visits (15183)
|
Open
|